Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Sanofi Genzyme.

Advances In™ Hematology: New Frontiers in the Treatment of TTP

Release Date: September 30, 2020
Expiration Date: September 30, 2021

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of thrombotic thrombocytopenic purpura (TTP) with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of disease classification and molecular testing, clinical trial data, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational initiative is directed toward medical hematologists and oncologists.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the criteria for TTP diagnosis, and the role of ADAMTS13 testing in diagnosis and risk-adapted treatment decision-making
  • Assess the efficacy and safety profile for current and emerging therapies in patients with TTP
  • Determine treatment-related toxicities and supportive care measures associated with current and emerging therapies for TTP in the context of approaches to maximize outcomes.
  • Apply evidence from landmark trials evaluating current and emerging therapies in TTP to real-world case scenarios in the management of patients with this disease.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Professor Marie Scully, MB BS, MRCP, FRCPath, MD
Professor Marie Scully, MB BS, MRCP, FRCPath, MD
Department of Hematology, UCLH
Cardiometabolic Programme-NIHR UCLH/UC BRC
London, United Kingdom

Disclosures: Grant/Research Support: Shire; Speaker’s Bureau: Takeda, Alexion, Novartis, Sanofi, Octapharma

Katerina Pavenski, MD
Katerina Pavenski, MD
Head, Division Transfusion Medicine, St. Michael’s Hospital, Unity Health Toronto
Associate Professor, Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto
Toronto, Canada

Disclosures: Grant/Research Support: HERCULES, Cadenza; Consultant: Sanofi, Takeda; Other: Sanofi, Alexion Pharmaceuticals

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By